QuantCapitol. Congressional Trading Intelligence

Updated nightly · Public disclosure record

88AVG SCORE

Keith Alan Self

House Republican TX
Oversight and InvestigationsDisability Assistance and Memorial AffairsSouth and Central AsiaSpace and AeronauticsEurope

Keith Alan Self has disclosed 11 stock transactions — 6 buys, 5 sells, each ranked by how much scrutiny it deserves and linked to its original House filing. A transparency record.

Last disclosed trade 2025-10-07 · last filing 2025-10-14

⚑
4 potential conflicts of interest. Self sits on committee(s) overseeing Defense, Health, Technology, and made 4 trades in those sectors (marked ⚑ below). This is a transparency signal, not an allegation of wrongdoing — such trades are often entirely legitimate.
11
Total trades
6
Buy
5
Sell
1
Avg. disclosure delay (days)
Trading profile
No trades in the past year Leans Technology (33% of trades) Mostly spouse accounts 55% buys Typical size $1K–$15K 6 different stocks 44% in sectors their committees oversee
A description of the disclosed trades, not a judgement: it says nothing about skill, intent or future returns.

Track record Congressional Trading Performance

Two figures per horizon, both hypothetical and not investment advice: Member's own — what the trade returned if you'd bought when Self did (not public yet, so not replicable); and If you'd followed — buying only after the disclosure went public, which is what a follower could actually do. The gap between them is the cost of the disclosure lag.

1 month
Member's own
-0.5%
-3.9% vs S&P 500
If you'd followed
-0.5%
-3.9% vs S&P 500
6 of 6 priced
3 months
Member's own
-6.8%
+2.8% vs S&P 500
If you'd followed
-6.8%
+2.8% vs S&P 500
6 of 6 priced
6 months
Member's own
+8.6%
+1.1% vs S&P 500
If you'd followed
+8.6%
+1.1% vs S&P 500
6 of 6 priced
1 year
Member's own
+17.4%
-2.1% vs S&P 500
If you'd followed
+17.4%
-2.1% vs S&P 500
6 of 6 priced
3 years
too recent
0 of 6 priced · 6 too recent

The count falls at longer horizons because recent trades haven't completed the full window yet — a return that hasn't happened is never estimated (no look-ahead). Only buys with usable price data are counted.

Round-trip watch Open positions

Stocks Self disclosed buying and has not disclosed selling, versus their entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised. Not investment advice.

TickerEntry (last buy)Entry priceNowvs entryStatus
PEP 2025-01-10 $133.11 $140.54 +5.6% ↩ near entry
GPC 2025-01-10 $109.23 $118.51 +8.5% in profit
NVDA 2025-01-10 $135.56 $125.53 -7.4% underwater

Price as of 2026-11-20. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Where they trade Favorite Sectors

Distribution of this politician's trades across sectors (of trades with a known sector — bonds and funds are excluded).

Technology
3 (33%)
Retail & Wholesale
2 (22%)
Food & Agriculture
2 (22%)
Health
1 (11%)
Telecommunications
1 (11%)

Traded the same stocks, same time Co-Investors in Congress

Other members who traded the same tickers within 30 days of Self's trades in them. A high overlap can reflect shared information, shared advisors, or simply popular stocks — it is not evidence of coordination.

PoliticianOverlapping tradesShared tickers
Rohit Khanna 15 MRK, NVDA, PEP
Josh Gottheimer 8 NVDA
Michael McCaul 7 GPC, NVDA, T
Marjorie Taylor Greene 6 NVDA
Julie Johnson 5 MRK, PEP
Nancy Pelosi 4 NVDA
Rob Bresnahan 4 NVDA
Valerie Hoyle 4 NVDA
Jared Moskowitz 3 MRK
John Boozman 2 NVDA
Sheldon Whitehouse 2 NVDA
Cleo Fields 2 NVDA

Corporate insiders · SEC Form 4 Overlap with Insiders

On the trades where corporate insiders were also active, how often did Keith Alan Self move the same way as the company's own officers and directors (within 60 days)? Co-occurrence only — context from public Form 4 filings, never proof of coordination, and tested honestly for whether it means anything.

22%
of checkable trades converged
avg 19% across all members
2
converged (of 9 checkable)
6
diverged

Keith Alan Self's convergence rate of 22% is higher than the 19% average across all members. "Checkable" = trades on tickers where insiders were also trading, so convergence could even be measured.

TickerDateTradeInsider convergence
LDOS 2025-10-07 SELL ◆ moderate · 4 insiders
MRK 2025-01-10 SELL ◆ moderate · 3 insiders

Descriptive only — insider convergence is context from public SEC Form 4 filings, never proof of coordination or wrongdoing, and not investment advice.

Trade → disclosure Timeline

Each bar runs from the day Keith Alan Self made a trade to the day it was disclosed, so the gap between the two is the stretch when only the member knew about it. Rows are the 6 most-traded tickers of the last two years. Dashed lines mark activity on bills in sectors Self's committees oversee. Hover for details. Timing only, never proof of anything.

Buy (trade → disclosure) Sell (trade → disclosure) Bill activity in an overseen sector
Bills on the timeline (10)
  • HRES 1673 — Supporting the goals and ideals of "National Rural Health Day". (2026-11-19, Health)
  • HR 10887 — Protecting Consumer Access to Generic Drugs Act of 2026 (2026-10-22, Health)
  • HR 10874 — Medicare Low Income Subsidy Equality Act of 2026 (2026-10-22, Health)
  • HR 10858 — CARE for Blood Cancer Act of 2026 (2026-10-22, Health)
  • HR 10810 — National Patient Safety Board Act of 2026 (2026-10-15, Health)
  • HR 10824 — Stroke Education and EMS Care Improvement Act of 2026 (2026-10-15, Health)
  • HR 10798 — Silicosis Prevention and Treatment Act (2026-10-13, Health)
  • HR 10806 — Medicare Home Health Payment Integrity and Protection Act of 2026 (2026-10-13, Health)
  • HR 10788 — Lower Premiums, Faster Payments Act (2026-10-09, Health)
  • HR 10787 — Access to Medical Supplies Act (2026-10-09, Health)

7 trades Recent Transactions

Marker key: ⚑ potential conflict (a committee Self sits on oversees that sector) · ◆ corporate-insider overlap from SEC Form 4 (convergence/divergence — context, not a signal) · % of NW trade size vs estimated net worth, 🔥 marking high/extreme conviction · OCR recovered from a scanned filing (verify against source) · ×N filings the same trade disclosed more than once (shown once). None is an allegation of wrongdoing.

TickerCompanyTypeDateFiledLagPrice move
in that
window
AmountScoreSource
⚑ LDOS Leidos Holdings, Inc. SELL ◆ insider convergence · moderate 2025-10-07 2025-10-14 7 days -4.9% $1K–$15K 99.2 ↗ filing
⚑ NVDA Nvidia Corp. BUY ◆ insider divergence 2025-01-10 2025-01-10 ×2 filings 0 days — $1K–$15K 100.0 ↗ 1 ↗ 2
⚑ MRK Merck & Co. Inc. SELL ◆ insider convergence · moderate 2025-01-10 2025-01-10 0 days — $1K–$15K 99.9 ↗ filing
GPC Genuine Parts Co. BUY ◆ insider divergence 2025-01-10 2025-01-10 ×2 filings 0 days — $1K–$15K 91.9 ↗ 1 ↗ 2
— Att SELL 2025-01-10 2025-01-10 ×2 filings 0 days — $1K–$15K 50.9 ↗ 1 ↗ 2
PEP Pepsico Inc. BUY ◆ insider divergence · moderate 2025-01-10 2025-01-10 ×2 filings 0 days — $1K–$15K 96.2 ↗ 1 ↗ 2
T At&T Inc. SELL 2025-01-10 2025-01-10 0 days — $1K–$15K 91.9 ↗ filing

A trade can appear in more than one filing (e.g. a periodic transaction report and a later annual disclosure). Those are shown once here — marked ×N filings, with a link to each — so the table reflects distinct trades, while the 11 total above counts every disclosed line.

FAQ Common questions

How many stock trades has Keith Alan Self disclosed?

11 disclosed stock transactions — 6 buys and 5 sells — all from official House financial disclosures.

Is this insider trading?

No. QuantCapitol surfaces the timing and context of publicly disclosed trades for transparency. A trade near related legislation is a coincidence we flag — never an accusation of wrongdoing.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

Embed Keith Alan Self's latest trades on your site

A small card with the latest disclosed trades that updates by itself. Free to use with the link back to QuantCapitol left in. Add ?theme=light to the address for a white card.

Writing about it? See the press page.
About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.